Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/35082
Type: Journal article
Title: Bisphosphonates and the osteonecrosis of the jaw
Author: Sambrook, P.
Olver, I.
Goss, A.
Citation: Australian Family Physician, 2006; 35(10):801-803
Publisher: Royal Australian College of General Practitioners
Issue Date: 2006
ISSN: 0300-8495
Statement of
Responsibility: 
Philip Sambrook, Ian Olver, Alastair Goss
Abstract: Recently an association between bisphosphonate use and a rare dental condition termed ‘osteonecrosis of the jaw’ (ONJ) has been reported. Patients with osteoporosis and Paget disease who take bisphosphonates have a significantly reduced risk of fracture and other skeletal complications. This represents significant health benefits, against which the small risk of ONJ needs to be considered. In patients with bone malignancy, the risk of ONJ needs to be balanced against the benefit of therapy on the underlying malignancy. There are still many uncertainties about this condition. This position paper seeks to summarise what is currently known about ONJ to provide information to medical practitioners and dental practitioners.
Keywords: Humans; Bone Neoplasms; Osteoporosis; Osteitis Deformans; Osteonecrosis; Jaw Diseases; Diphosphonates; Practice Guidelines as Topic
Description: Copyright © 2006 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.
RMID: 0020062574
Published version: http://www.racgp.org.au/afp/200610/12539
Appears in Collections:Dentistry publications

Files in This Item:
File Description SizeFormat 
hdl_35082.pdf244.7 kBPublisher's PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.